Septerna discontinues phase 1 clinical trial of SEP-786; plans to advance next-generation oral small molecule PTH1R agonist: South San Francisco, California Friday, February 21, 2 ...
Aidoc receives US FDA clearance for first foundation model-powered clinical artificial intelligence solution: New York Friday, February 21, 2025, 14:00 Hrs [IST] Aidoc, a global l ...
Chugai obtains Japanese regulatory approval for Tecentriq for additional indication of alveolar soft part sarcoma, an ultra-rare disease: Tokyo Friday, February 21, 2025, 10:00 Hr ...
China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease: London, UK Friday, February 21, 2025, 09:00 Hrs [IST] GSK plc announ ...
TN DCA tightens noose on violators of drug laws as 221 prosecutions were issued in 10 months: Peethaambaran Kunnathoor, Chennai Friday, February 21, 2025, 08:00 Hrs [IST] The drug ...
Pharmexcil to host seminar on market access issues for pharmaceutical: Shardul Nautiyal, Mumbai Friday, February 21, 2025, 08:00 Hrs [IST] The Pharmaceuticals Export Promotion Cou ...
DGFT introduces mandatory online submissions & digital payments for enforcement & adjudication proceedings: Shardul Nautiyal, Mumbai Friday, February 21, 2025, 08:00 Hrs [IST] In ...
Krupacon 2025 underscores technology, acumen, green initiatives to pave the future of pharma: Nandita Vijayasimha, Bengaluru Friday, February 21, 2025, 08:00 Hrs [IST] The future ...
Pharmaceuticals exports register highest growth at 21.5% in January: Gireesh Babu, New Delhi Friday, February 21, 2025, 08:00 Hrs [IST] Exports of drugs and pharmaceuticals from I ...
ZEISS India with Indian Institute of Science sets up research lab on AI for eye care: Our Bureau, Bengaluru Thursday, February 20, 2025, 15:30 Hrs [IST] ZEISS India collaborated w ...
Acurx Pharmaceuticals’ DNA Polymerase IIIC Inhibitors receives Japanese patent: Staten Island, New York Thursday, February 20, 2025, 18:00 Hrs [IST] Acurx Pharmaceuticals, Inc., ...
Genprex advances diabetes programme with addition of research focused on non-viral delivery system: Austin, Texas Thursday, February 20, 2025, 16:00 Hrs [IST] Genprex, Inc., a cli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results